Your browser doesn't support javascript.
loading
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
Brien, Gerard L; Remillard, David; Shi, Junwei; Hemming, Matthew L; Chabon, Jonathon; Wynne, Kieran; Dillon, Eugène T; Cagney, Gerard; Van Mierlo, Guido; Baltissen, Marijke P; Vermeulen, Michiel; Qi, Jun; Fröhling, Stefan; Gray, Nathanael S; Bradner, James E; Vakoc, Christopher R; Armstrong, Scott A.
Afiliación
  • Brien GL; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, United States.
  • Remillard D; Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
  • Shi J; Department of Medical Oncology, Dana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, United States.
  • Hemming ML; Department of Cancer Biology, Dana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, United States.
  • Chabon J; Department of Cancer Biology, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
  • Wynne K; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, United States.
  • Dillon ET; Department of Medical Oncology, Dana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, United States.
  • Cagney G; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, United States.
  • Van Mierlo G; School of Biomolecular and Biomedical Science and Conway Institute, University College Dublin, Dublin, Ireland.
  • Baltissen MP; School of Biomolecular and Biomedical Science and Conway Institute, University College Dublin, Dublin, Ireland.
  • Vermeulen M; School of Biomolecular and Biomedical Science and Conway Institute, University College Dublin, Dublin, Ireland.
  • Qi J; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Fröhling S; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Gray NS; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.
  • Bradner JE; Department of Cancer Biology, Dana Farber Cancer Institute, Boston Children's Hospital and Harvard Medical School, Boston, United States.
  • Vakoc CR; German Cancer Consortium, Heidelberg, Germany.
  • Armstrong SA; Section for Personalized Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Elife ; 72018 11 15.
Article en En | MEDLINE | ID: mdl-30431433
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Regulación Neoplásica de la Expresión Génica / Sarcoma Sinovial / Proteolisis Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Elife Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Regulación Neoplásica de la Expresión Génica / Sarcoma Sinovial / Proteolisis Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Elife Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos